Avantor Inc (AVTR)
25.83
-0.23
(-0.88%)
USD |
NYSE |
Sep 27, 16:00
25.82
-0.01
(-0.04%)
Pre-Market: 20:00
Avantor SG&A Expense (TTM): 1.585B for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 1.585B |
March 31, 2024 | 1.537B |
December 31, 2023 | 1.507B |
September 30, 2023 | 1.482B |
June 30, 2023 | 1.489B |
March 31, 2023 | 1.483B |
December 31, 2022 | 1.473B |
September 30, 2022 | 1.543B |
June 30, 2022 | 1.547B |
March 31, 2022 | 1.567B |
December 31, 2021 | 1.530B |
September 30, 2021 | 1.474B |
Date | Value |
---|---|
June 30, 2021 | 1.424B |
March 31, 2021 | 1.377B |
December 31, 2020 | 1.374B |
September 30, 2020 | 1.325B |
June 30, 2020 | 1.327B |
March 31, 2020 | 1.375B |
December 31, 2019 | 1.369B |
September 30, 2019 | 1.374B |
June 30, 2019 | 1.390B |
March 31, 2019 | 1.391B |
December 31, 2018 | 1.406B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
1.325B
Minimum
Sep 2020
1.585B
Maximum
Jun 2024
1.458B
Average
1.478B
Median
SG&A Expense (TTM) Benchmarks
Revvity Inc | 1.019B |
Agilent Technologies Inc | 1.564B |
Bio-Rad Laboratories Inc | 817.95M |
Bruker Corp | 805.40M |
Azenta Inc | 305.65M |